Skip to main content

Research Repository

Advanced Search

The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease

Ng, Jen M.; Cooke, Michelle; Bhandari, Sunil; Atkin, Stephen L.; Kilpatrick, Eric S.

Authors

Jen M. Ng

Michelle Cooke

Sunil Bhandari

Stephen L. Atkin

Eric S. Kilpatrick



Abstract

OBJECTIVE - To examine the effect of intravenous iron and erythropoietin-stimulating agents (ESAs) on glycemic control and A1C of patients with diabetes and chronic kidney disease (CKD). RESEARCH DESIGN AND METHODS- This was a prospective study of patients with type 2 diabetes and CKD stage IIIB or IV undergoing intravenous iron (group A) and/or ESA (group B). Full blood profiles were determined over the study period. Glycemic control was monitored using A1C, seven-point daily glucose three times weekly, and continuous glucose monitoring (CGM). RESULTS - There were 15 patients in both group A and group B. Mean A1C (95% CI) values fell in both groups (7.40% [6.60-8.19] to 6.96% [6.27-7.25] , P < 0.01, with intravenous iron and 7.31% [6.42-8.54] to 6.63% [6.03-7.36] , P = 0.013, ESA). There was no change in mean blood glucose in group A (9.55 mmol/l [8.20-10.90] vs. 9.71 mmol/l [8.29-11.13] , P = 0.07) and in group B (8.72 mmol/l [7.31-10.12] vs. 8.78 mmol/l [7.47-9.99] , P=0.61) over the study period. Hemoglobin and hematocrit values significantly increased following both treatments. There was no linear relationship found between the change in A1C values and the rise of hemoglobin following either treatment. CONCLUSIONS - Both iron and ESA cause a significant fall in A1C values without a change to glycemic control in patients with diabetes and CKD. At the present time, regular capillary glucose measurements and the concurrent use of CGM remain the best alternative measurements of glycemic control in this patient group.

Citation

Ng, J. M., Cooke, M., Bhandari, S., Atkin, S. L., & Kilpatrick, E. S. (2010). The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care, 33(11), 2310-2313. https://doi.org/10.2337/dc10-0917

Journal Article Type Article
Online Publication Date Aug 26, 2010
Publication Date Nov 1, 2010
Deposit Date Nov 13, 2014
Publicly Available Date Nov 13, 2014
Journal Diabetes care
Print ISSN 0149-5992
Publisher American Diabetes Association
Peer Reviewed Not Peer Reviewed
Volume 33
Issue 11
Pages 2310-2313
DOI https://doi.org/10.2337/dc10-0917
Keywords Internal Medicine; Endocrinology, Diabetes and Metabolism; Advanced and Specialised Nursing
Public URL https://hull-repository.worktribe.com/output/463254
Publisher URL http://care.diabetesjournals.org/content/33/11/2310
Additional Information Authors' accepted manuscript of article published in: Diabetes care, 2010, v.33, issue 11
Contract Date Nov 13, 2014

Files




Downloadable Citations